From fending off 89 competitors with one computer graphics textbook to making non-consensus bets on AI/Robotics, how NVIDIA has become a $2T market leader
From Mark Cuban's CostPlusDrugs to Good AI, how healthcare can finally be made accessible to all
FDA approves two gene therapies for sickle cell disease, including first that uses CRISPR/Cas9